Skip to main content
PLOS One logoLink to PLOS One
. 2024 Jun 26;19(6):e0306122. doi: 10.1371/journal.pone.0306122

Impacts of Long COVID on workers: A longitudinal study of employment exit, work hours and mental health in the UK

Darja Reuschke 1,*, Donald Houston 1, Paul Sissons 2
Editor: Gabriel A Picone3
PMCID: PMC11207153  PMID: 38924025

Abstract

Background

The COVID-19 pandemic has had enormous implications for the world of work. However, there has been relatively little focus on the employment and workforce challenges of the virus in relation to workforce health, beyond the immediate management of the spread of the disease. There is an important gap in understanding the ongoing workforce issues created by the significant incidence of Long COVID in the population.

Aim

This paper examines the effects of Long COVID on employment and workers’ mental health to contribute to understanding of work-limiting health conditions and to offer policy implications for COVID-19 and similar health conditions on employment and the workforce.

Methods

A large national panel study for the UK is used to estimate the likelihood of exiting employment as well as on changes in working hours and general mental health and happiness of those who remain in work. The sample includes individuals 16 years and older who were in employment in January/February 2020 and followed during the pandemic 2020–2021. Long COVID is self-reported in the data. Informed by conceptual consideration of employment protection in the UK, two groups of individuals with Long COVID are defined based on the duration of symptoms. Group 1 has Long COVID 5–28 weeks after an infection with COVID-19, which is up to the maximum length of Statutory Sick Pay in the UK. Group 2 has symptoms for 29+ weeks, which is beyond the statutory entitlement to sickness pay. Panel regression models are fitted both with fixed-effects and random-effects. Individual and job characteristics are used as controls Those with no COVID-19 symptoms are the reference group.

Results

In between-person comparison, Group 2 is at higher risk of exiting employment compared to those with no COVID-19 symptoms. Between-person estimates of mental health and well-being show negative effects of Long COVID for both groups but these are greatest in Group 2. Within-person estimates suggest that factors associated with earnings mediate the negative Long COVID effects on mental health in Group 1 and that Group 2 adapts to working with Long COVID. Group 1 is at risk of working zero hours (i.e. being on sick leave) but neither Group 1 nor Group 2 have a higher probability of working fewer hours compared to those with no COVID-19 symptoms. The negative impact of Long COVID on working hours stems primarily from working zero hours (sickness leave) rather than working fewer hours, suggesting a lack of accommodation by employers of Long COVID at work.

Policy implications

The extension of Statutory Sickness Pay and greater flexibility to manage partial (returns to) work would help preserve employment and mental health. Those with Long COVID for 12 months are likely to meet the definition of disability and so have a right to receive reasonable workplace adjustments.

1. Introduction

Long COVID describes a long-term debilitating illness following an infection with the SARS-CoV-2 virus. It is conceptually defined as persistent COVID-19 symptoms or late complications of the virus infection that develop at least five weeks after an initial infection with the virus [1, 2]. Symptoms of Long COVID are multidimensional and can include chronic or episodic physical, cognitive or mental illness [35]. Fatigue, breathing problems, inability to concentrate and muscle pain are common [6, 7] and can pose significant limitations on daily activities [8]. Symptoms often fluctuate or relapse [2, 9]. Worldwide an estimated 65 million people have had Long COVID [10]. It affects individuals of all ages [10] but those between 45–54 are at greatest risk [8]. Double vaccination only gives modest protection [11]. It is estimated that 10–12% of the vaccinated population develop Long COVID following a COVID-19 infection [10]. The higher prevalence of Long COVID in people of working-age and the withdrawal of public vaccination programmes for those under 65 years of age in the UK mean that Long COVID is set to have a significant and lasting impact on individuals’ health, employment and earnings. There is currently no effective treatment for Long COVID and it can be difficult to clinically diagnose [10].

The onset of long-term illness can have three contrasting, although not mutually exclusive, negative impacts on employment outcomes with consequences for both employees and employers: i) leaving the labour market, either on a permanent or temporary basis until health may recover; ii) reducing hours worked in order to accommodate health problems, including sickness absence; or iii) continuing in existing work arrangements, with possible further consequences for the health and well-being. In addition to the impacts of long-term illness such as Long COVID itself on mental health and job loss, impaired ability to work can have further significant negative impacts on mental health.

Given the large numbers of the population reporting Long COVID [6, 10] and a sharp rise in economic inactivity (those neither working nor seeking or available for work) and resultant labour shortages [12], it is surprising that little robust evidence is available on the potential workforce impacts [1]. Narratives about the impact of the pandemic on the workforce have tended to focus on lifestyle reappraisal such as the ‘Great Retirement’ and only recently have begun to acknowledge that the pandemic’s direct health impact may be an important driver of rising ill-health and economic inactivity. This paper aims to help address this gap through providing evidence on the impacts of Long COVID on workers using data for the United Kingdom (UK). The focus is on employment outcomes as well as the mental health outcomes of those in employment covering a range of impacts of Long COVID on workers.

The main contribution of this study is to provide robust evidence on the impact of COVID-related health conditions on employment. This is an important contribution to social epidemiology and public health studies, which overwhelmingly focus on the impact of employment on health [13]. The morbidity effects of the COVID-19 pandemic have been documented and, therefore, research is now needed on how developing Long COVID affects employment and in-work experiences. As with other difficult-to-diagnose illnesses with varied symptoms such as chronic fatigue syndrome, research is also needed to reveal and change the societal misperceptions, stigma and discrimination experienced by people and employees with ‘unrecognised’ diseases where individuals usually do not have a specific diagnosis [1416]. We use a large national longitudinal survey of people 16 years and older and multi-variate panel regression modelling to estimate how the development of Long COVID has changed individuals’ employment and in-work experience.

2. Context and existing evidence

Poor health and disability (a health condition that has lasted or is expected to last more than 12 months and limits daily activity) carry large penalties for employment [17]. Chronic illnesses, disabilities and mental health conditions have been associated with labour market exit and barriers for re-employment [1820]. Disabilities and poor health have also been associated with worse in-work experiences compared to non-disabled employees in relation to contentment, perception of fairness, well-being and job satisfaction [21, 22]. These health-related inequalities in work experiences have been conceptualised through multiple interconnected factors related to individual characteristics (e.g. type of disability), context (legislation) and at the organisational level factors including discrimination and the lack of workplace accommodations and provision of support [23, 24]. Long COVID, as a new complex illness, raises therefore important questions about employment outcomes and in-work experiences. Investigating work outcomes of Long COVID adds to previous studies on work-limiting conditions through focussing on an illness which is often associated, similar to chronic fatigue syndrome, with comorbid health conditions and people often do not receive appropriate treatment and are not eligible for disability benefits [18].

Studies on Long COVID have suggested large negative effects of developing the illness on quality of life due to the major challenges posed by physical health conditions, problems with mental health including anxiety and depression and the unpredictability of symptoms [7, 2528]. Scientific evidence on the impact of Long COVID on employment and in-work experiences are limited as most existing studies have been based on samples not designed to investigate consequences for work and employment, in particular studies based on samples of hospitalised patients [29] or limited to individuals with COVID-19 symptoms or self-reported Long COVID [7, 9] with no comparator or control group. A limited number of studies have recruited small non-random samples of workers to describe experiences of workers with Long COVID [30, 31]. These scientific limitations notwithstanding, existing evidence suggests that Long COVID creates burdens for the ability to return to work due to the severity of the symptoms and their fluctuating nature [31]. Existing UK studies, based on different sampling strategies, found an increased level of sickness leave due to Long COVID both in hospitalised and not hospitalised patients [7, 32].

Long COVID is associated with stigma as the health conditions are poorly understood and difficult for health services to manage [16]. Many Long COVID sufferers do not have a medical diagnosis [14]. There is no scientific evidence on Long COVID stigma and worker experiences but studies have increasingly shown that health-related stigma by employers, co-workers and others such as health care professionals and customers is a barrier to employment and well-being at work of people with disabilities [33]. A survey by the Trade Union Congress drawing on a self-selective sample of 3,000 respondents with Long COVID, states that 66 per cent of respondents reported they had received unfair treatment at work, and 23 per cent reported their employer had queried whether they had Long COVID or the severity of their symptoms [34].

Long COVID may often limit daily activities for less than 12 months, but it is often long enough to impact on employment and mental health, not least since the UK’s Statutory Sick Pay (SSP) system only protects employment for six months (28 weeks) following the onset of a health problem and payment levels are unrelated to normal earnings as in insurance-based schemes. To provide some context, in the UK, only around half of employers have occupational sick pay schemes which pay a higher rate than statutory requirements and few extend beyond six months [35]. SSP is available to employees meeting the health and earnings criteria but who are not covered by an occupational sick pay scheme. SSP is relatively ungenerous (up to £99.35 GBP per week) and is set at a flat rate, rather than providing a level of compensation relative to salary [36]. SSP is also relatively inflexible, creating difficulties around phased returns to work. Longer-term periods of ill-health therefore often precipitate the termination of employment and necessitate a claim to out-of-work sickness benefits [37].

There are also significant differences in access to occupational health support to enable workers to remain in work. Large and public sector employers are more likely to offer access to occupational health services, while lower paid and lower qualified employees, those working in smaller firms, are less likely to have access to such services [38]. In terms of disability support for those in work, there is also evidence to suggest that access to supportive practices are not evenly distributed among the workforce, and that support for invisible disabilities by employers and colleagues may be more limited than for more visible conditions [39].

Together, these gaps in the sick pay system and inequalities in the coverage of occupational health support represent important limitations in the provision of support to allow individuals to remain in work while managing health conditions in the UK. However, no existing study has investigated the association between work outcomes of Long COVID and the length of employment protection in law and how the employment and in-work experiences of Long COVID may be mitigated by certain worker or job characteristics (e.g. skills level, earnings).

3. Data and methods

3.1 Survey data

The dataset used is the Understanding Society COVID-19 Study 2020–2021, which draws on a large household panel study, Understanding Society (USoc), which started in 2009 with a nationally representative sampling frame. The data are available to researchers who are registered with the UK Data Service [40]. The present study has received ethical approval from the Humanities and Social Sciences Committee at the University of Birmingham (ERN_2069).

The first survey round of the USoc COVID-19 Study was conducted in April 2020, soon after the onset of the pandemic, administered online to all adult members 16 years and older of the annual panel study (n = 42,330), and again every month until July 2020, thereafter every two months until March 2021, with a last wave in September 2021 (wave 9). In the first wave, 17,745 individuals completed the survey [41]. Individuals could also join the study in waves 2–4. In total, across all nine waves, 19,763 individuals participated in the study. However, as in all longitudinal surveys, there is an issue with panel attrition. From all individuals who participated in the study, 40.5% participated in every wave. A relatively high proportion of 9.5% only participated in wave 1 (April 2020).

The USoc COVID-19 Study 2020–21 can be linked with the USoc main panel study [42]. This allows the linkage of pre-COVID-19 characteristics to the COVID-19 survey data. We use participant’s 2019 interview for additional pre-COVID-19 information. The USoc COVID-19 Study ended before the spike in COVID-19 infections caused by the BA.2 Omicron virus. However, the design and breadth of the USoc COVID-19 Study including information on individuals pre-COVID characteristics, allow an in-depth investigation of employment effects not possible with other secondary survey data.

3.1.1 Measuring long COVID

The study started in April 2020 (wave 1) but only in the three surveys in January, March and September 2021 (waves 7–9) a question on the duration of coronavirus symptoms was included in the questionnaire and asked from those who previously reported that they had COVID-19 symptoms and had not returned to previous health or who reported COVID-19 symptoms in the current survey (“For how many weeks have you experienced coronavirus symptoms?”). In line with the UK Office for National Statistic’s Community Infection Survey, we define Long COVID as having had COVID-19 symptoms for five weeks and more [6]. From the initially recruited participants, n = 15,249 were still in the study at least once over the waves 7–9 and n = 9,678 individuals were in the study in each of these three waves our study is based on.

Our focus is on the health-related COVID-19 impact on employment and in-work experiences of those who remain in work. Longer-term periods of ill health that extend the maximum period of Statutory Sickness Pay of 28 weeks in the UK, often precipitate the termination of employment [35]. This is the maximum period we expect especially low-paid workers and those in more insecure employment positions to be more likely to leave employment. Those on lower income and in lower skilled jobs in particular, may need to work even if they are unwell which may result in lower in-work experiences. This is the rationale for deriving two groups of individuals with Long COVID for this study: 1) 5–28 weeks of symptoms and 2) symptoms of 29 weeks and more. For comparison, we define a further two groups of respondents with 3) COVID-19 symptoms of less than five weeks (short COVID) after a COVID-19 infection and 4) a group with no symptoms including recovery from a previous coronavirus infection (used as reference group in the modelling). This is our preferred measure of Long COVID for this study. However, when estimating employment exit, we also use a binary (total) measure of Long COVID (see section 3.3.1). This measure defines as Long COVID all those who reported that they have not recovered from a COVID-19 infection or who had experienced coronavirus symptoms for five weeks and more [32]. The comparison group on this binary measure are respondents with no COVID-19 symptoms or who recovered from a coronavirus infection.

Some people answered in the same interview that they have not recovered from a coronavirus infection which they reported in a previous interview and that they have experienced at the time of the interview coronavirus symptoms for fewer than five weeks. It is likely that these respondents have reported a re-infection with COVID-19 on top of their Long COVID. We do not include these observations in our duration-based Long COVID measure since no reliable information is available on respondent’s length of Long COVID.

3.1.2 Measuring employment and mental health outcomes

Respondents were asked about their work status (employed, self-employed, both employed and self-employed, none) in January/February 2020 retrospectively when they first entered the survey and for each wave of the USoc COVID-19 Study. Those who were furloughed were asked to report their work status as being employed. From this we derive a binary variable capturing exit from employment (paid employment or self-employment) compared to having remained in employment. The survey does not differentiate between economic inactivity and unemployment so that we cannot differentiate between these outcomes.

We further explore employment outcomes for those who remain in employment using number of hours worked to test whether Long COVID is associated with a reduction in working hours.

In addition, two measures of mental health and well-being are examined. From the General Health Questionnaire comprising of 12 questions (GHQ-12) we use the Likert scale ranging from 0 to 36 with 0 indicating the least distressed and 36 the most distressed as a measure of general mental health. From the GHQ-12, the single question on happiness is used as a measure of subjective well-being. It has been used to study performance at work and is therefore useful to examine in-work experiences in our study alongside the full GHQ-12 [43]. The happiness question measures whether individuals feel more happy than usual (coded 1) to much less happy than usual (coded 4). We reverse both the Likert and the happiness scales so that in our modelling findings, positive (negative) values indicate a higher (lower) level of mental health and well-being.

3.2 Sample

Our sample draws on survey responses in waves 7–9 (January-September 2021) of the USoc COVID-19 Study in which the question on the duration of COVID-19 symptoms was included. We select respondents who were in employment in January/February 2020. For estimating employment exit, we use a sample of 9,288 individuals with at least one observation between January-September 2021 (Sample 1). For some analysis, we further restrict this sample only to individuals for whom we have information on their employment status in at least two waves (from waves 7–9).

We derive a second sample that includes observations from individuals in employment both in January/February 2020 and in waves 7–9 (Sample 2). The sample size are 20,225 wave-observations (n = 8,708 individuals). The sample size in the multi-variate analysis varies depending on the outcome variable and the modelling frame used.

The second employment sample contains n = 1,906 wave-observations of working zero hours (9.5% of all wave-observations), the average number of number of hours worked of those who worked at least one hour is 34.36 (sd = 13.0), the average reversed GHQ-12 score is 23.6 (sd = 5.8) which is within the range of the expected mental health score, and the highest proportion (48%) of the sample reports that they are no more unhappy or depressed than usual (mean = 3.0, sd = 0.8). A summary of the dependent variables by our duration-based Long COVID variable is shown in Table 1. A sample description of all co-variates used in the multi-variate analysis is shown in the Supplementary Documentation (S1 Appendix).

Table 1. Description of dependent variables by COVID-19 symptoms-duration categories.

Dependent variables No COVID-19 symptoms Short COVID: <5 weeks Long COVID: 5–28 weeks Long COVID: 29+ weeks
Sample 1
Employment in wave 7–9 (n = 22,106)
    Employed 91.3% 94.1% 91.6% 89.6%
    Not employed 8.7% 5.9% 8.4% 10.4%
Sample 2
Works zero hours in wave 7–9 (n = 19,979)
    Yes, works zero hours 9.2% 10.8% 20.2% 11.1%
    No, works at least 1 hours 90.8% 89.2% 79.8% 88.9%
Mean number of hours worked in wave 7–9, if worked at least 1 hour (n = 18,073) 34.3 34.7 35.3 33.2
Mean reversed GHQ-12 score, wave 7–9 (n = 19,659) 23.79 22.64 20.15 20.82
Mean reversed happiness score, wave 7–9 (n = 19,729) 3.03 2.89 2.63 2.66

Source: Understanding Society COVID-19 Study 2020–2021, waves 7–9, unweighted data

The sample description in Table 1 shows an increased proportion of respondents not being employed in waves 7–9 among those with Long COVID 29+ weeks. Those with Long COVID symptoms within the Statutory Sickness Pay period (5–28 weeks), have a similar proportion of respondents out of employment compared to those who have no COVID-19 symptoms (including having recovered from a previous COVID-19 infection). In the descriptive data, among respondents who have remained in employment, the proportion of those working zero hours is substantially higher among those with Long COVID 5–28 weeks compared to those with no COVID-19 symptoms although if still working at least one hour per week, this Long COVID group works on average an hour longer than those with no COVID-19 symptoms. Those with Long COVID 29+ weeks have a slightly higher proportion of respondents working zero hours compared to the group of respondents with no COVID-19 symptoms and their mean working hours (if they are still working) is lowest of all groups. The mean GHQ-12 and happiness scores show large differences across the four groups. For both Long COVID groups, the scores are substantially lower indicating lower mental health and well-being.

3.3 Analytical framework

We have panel data (individuals i observed at different times t) and estimate both random-effects and fixed-effects panel models for each of the set of employment and mental health outcomes. Stata 16 is used for the statistical analysis.

The fixed-effects panel model estimates within-individual variation and requires that the same individual is observed twice, once when they experienced COVID-19 symptoms and once when they did not experience COVID-19 symptoms. These models include an error term that represents individual-specific unmeasured characteristics and therefore allow to control for unobserved heterogeneity due to time-invariant omitted variables and traits. The disadvantage is, however, that individuals in our study who experienced Long COVID in all three subsequent waves, are not included in the statistical analysis.

This is why we also report random-effects models which estimate between-individual variation and within-individual variation. These models, however, assume that the error term is not correlated with unobserved time-invariant (and time-variant) variables. Random-effects models allow the investigation of time-invariant characteristics which we also report. We include as time-invariant variables pre-COVID-19 job characteristics of the respondents which we link to the survey data from the main panel study.

3.3.1 Employment exit

We estimate the probability of having moved from employment to non-employment with logistic regression models. Unfortunately, we cannot fit a logistic regression model with fixed effects using our duration-based measure. The model requires that people have experienced between subsequent waves changes in the work status and COVID-19 symptoms categories. We can fit a logistic regression model with fixed effects using the binary (total) Long COVID measure (COVID-19 symptoms 5+ weeks vs <5 weeks including no symptoms and recovery from COVID-19). We report random-effects findings for the duration-based measure of Long COVID (no symptom, short COVID, Long COVID 5–28 weeks, Long COVID 29+ weeks).

3.3.2 Working time

We estimate effects of Long COVID on working hours using a two-step approach. First, we use a binary logistic regression with working zero hours as dependent variable and, second, a log-linear regression model of working hours.

3.3.3 Mental health and well-being

We regress the reversed and standardised GHQ-12 score using linear panel regressions (positive/negative values indicate better/lower mental health, see 3.1.2). For the reversed 4-item happiness scale which measures whether respondents are less happy or much happier compared to their usual status, ordered logistic panel regression models are fitted.

3.3.4 Co-variates

In the fixed-effects regression panel models, co-variates included are the age of the respondents and age squared, two variables indicating whether a partner/spouse and a child 0–15 years of age live in the household, and wave dummies. Time-invariant characteristics are included in the error term.

For estimating the effects of Long COVID on the number of hours worked and mental health and well-being, the following (time-variant) variables are also added in the fixed-effects models: industry sectors and employment status (employee vs self-employed), based on the large variations of working conditions across sectors and the disproportionate impact of the pandemic on self-employed work (note that these are not added in the model of working zero hours due to the small number of observations). In models of mental health and well-being, we further include as a co-variate hourly earnings as lower incomes have been associated with poorer mental health [44].

In the random-effects panel regression models, a comprehensive set of co-variates of personal characteristics is added to the above time-variant variables: sex, highest education, ethnicity, region, and a long-standing health condition in the year preceding the pandemic (from the main panel interview) (see S1 Appendix). Previous research has shown that the prevalence of Long COVID is greater in people with another activity-limiting health condition or disability, in particular asthma, lung disease or heart disease [45].

In the employment exit random-effects models, we further add as pre-COVID-19 characteristics: industry sector, number of hours worked, a temporary (versus permanent) contract, self-employment and hourly earnings, taken either from the 2019 main panel interview or from retrospective information for January/February 2020 collected in the USoc COVID-19 survey.

3.3.5 Robustness checks

As robustness checks for models of hours worked and mental health, we derive measures of change between the respondent’s interview that fell into waves 7–9 and their number of hours work in January/February 2020 and their GHQ-12 score in 2019 (from the USoc main panel interview). The GHQ-12 change score is standardised and reversed so that negative (positive) values indicate a decline (increase) in mental health. Linear regression models are used to examine whether Long COVID is related with a reduction in hours worked or decline in mental health for the same individuals including controls (3.3.4).

4. Results

4.1 Employment exit

Findings on whether Long COVID is connected with an increased risk of leaving the workforce, are summarised in two models in Table 2. The data, unfortunately, do not allow the investigation of Long COVID using the duration-based measure of Long COVID in a fixed-effects (FE) model framework (which requires change in work status and in the four COVID-19 symptoms groups). However, a fixed-effects logistic regression model is fitted using the binary measure of Long COVID (COVID-19 symptoms 5+ week or not). These results are displayed in Model 1 (Table 2). Model 2 (Table 2) uses the duration-based measure of Long COVID with no COVID-19 symptoms as reference group in the random-effects panel framework. Results are shown in odds ratio (OR). The number of wave-observations and of individuals between the fixed-effects (FE) and random-effects (RE) model are strikingly different as the fixed-effects models only uses wave-observations from individuals who experienced both a change in work status and Long COVID. The random-effects model instead estimates the odds of an employment exit for the four COVID-19 symptoms groups and controls. Odds ratios larger (smaller) than 1 indicate that an employment exit has greater (fewer) odds of occurring with the co-variate.

Table 2. Employment exit, odds ratios and standard errors.

Co-variates M1 –FE M2 –RE
Long COVID 5+ weeks 1.360 0.707 -
COVID-19 symptoms (Ref. none)
    <5 weeks - 1.209 0.297
    5–28 weeks - 1.381 0.707
    29+ weeks - 3.523* 1.959
Age 0.190*** 0.082 0.627*** 0.209
Age2 1.018*** 0.004 1.006*** 0.001
Child 0–15 3.431* 2.129 0.492** 0.122
No partner (Ref. couple) 0.929 0.370 1.169 0.222
Female - 0.751 0.155
Ethnicity (Ref. White British)1
    White, other - 1.824 0.766
    Asian - 3.182** 1.192
    Black - 2.381 1.301
Qualification (Ref. high)
    Medium - 1.044 0.209
    Low - 1.119 0.394
Pre-pandemic characteristics (2019/2020)
Long-standing health cond. - 1.717** 0.326
Temporary job - 2.712*** 0.742
Self-employed - 0.170*** 0.059
Industry (Ref. SIC-KLMN)1,2
    SIC CDEF - 1.435 0.532
    SIC GI - 1.529 0.524
    SIC HJ - 2.870** 1.112
    SIC OPQ - 1.257 0.361
    SIC RSTU - 1.022 0.484
Hours worked - 0.926*** 0.008
Net earnings/hour (logged) - 0.764 0.128
Wave-obs. 1,142 16,735
Individuals 407 7,085
LR Chi2(df) / Wald Chi2(df) 58.9(7) 408.8(39)

Source: USoc COVID-19 Study 2020–2021, waves 7–9. Sample of respondents who were in work in Jan/Feb 2020. Wave dummies are included in all models and region dummies in the RE models.

Significance level

***p<0.001

**p<0.01

*p<0.05.

1 Categories with small cell sizes not shown.

2 CDEF-manufacturing, electricity, gas, water, construction; GI-retail, wholesale, hospitality; HJ-transport, information and communication; KLMN-finance, insurance, professional & admin. Services; OPQ-public admin., health, social, education; RSTU-other personal services.

The binary (total) measure of Long COVID is not significantly related with an exit from employment in the fixed-effects model (Model 1, Table 2). The odds ratio is increased (OR = 1.36, sd = 0.7) but not significantly larger than Zero. The duration-based measure of COVID-19 symptoms instead shows a large and significant increase of the odds of those with Long COVID 29+ weeks (OR = 3.5, sd = 1.9) to have exited the workforce compared to those who did not have COVID-19 symptoms or have recovered from a COVID-19 infection (Model 2, Table 2). In comparison, those with Long COVID 5–28 weeks (that is within the Statutory Sickness Pay period) and those with short COVID (<5 weeks) do not have significantly higher odds of not being in employment any more than those with no COVID-19 symptoms.

Long COVID and a previous long-standing health condition are interrelated in our sample (e.g. 53% of respondents with COVID-19 symptoms for 29+ weeks reported a previous health condition compared to 28% of respondents with no COVID-19 symptoms). Previous research has also shown that the prevalence of Long COVID is greater in people with another activity-limiting health condition or disability, in particular asthma, lung disease or heart disease [45]. Importantly, however, findings in Model 2 in Table 2 show that the odds of an employment exit are twice as high for Long COVID for 29+weeks to a previous long-standing health condition (OR = 3.5, sd = 1.9 compared to OR = 1.7, sd = 0.3).

In both model frameworks, findings show an inverse relationship with age suggesting that both young and older people left the workforce. Furthermore, the random-effects model framework (Model 2) reveals an increased risk of employment exit of Asian people (OR = 3.2, sd = 1.2), those with insecure (temporary) jobs (OR = 2.7, sd = 0.7) or those who worked fewer hours before the outbreak of the pandemic (OR = 0.9, sd = 0.01). The only industry sector that shows a significant positive relationship with an employment exit compared to the advanced service sector is the combined category of transport, information and communication (OR = 2.9, sd = 1.1).

4.2 Working hours

Findings in Table 3 show whether Long COVID has had a negative impact on the number of hours worked (of those still in employment). Models 1 and 2 estimate the risk of working zero hours using fixed-effects (FE) and random-effects (RE). Results are shown in odds ratio. Using observations from individuals who worked at least one hour in the reference week (see Table 1), Models 3 and 4 estimate the effect of Long COVID and controls on number of working hours (logged) first with fixed-effects (FE) and then with random-effects (RE).

Table 3. Zero hours worked (odds ratios) and working hours (coefficients).

Co-variates Works zero hours–OR Working hours (logged)–Coeff.
M1 –FE M2 –RE M3 –FE M4 –RE
COVID-19 symptoms (Ref. none)
    <5 weeks 1.898*** (0.331) 2.137*** (0.318) -0.012 (0.011) 0.016 (0.010)
    5–28 weeks 2.145* (0.701) 3.614*** (1.042) -0.033 (0.027) -0.017 (0.024)
    29+ weeks 0.704 (0.406) 1.129 (0.508) 0.018 (0.039) 0.011 (0.033)
Age 0.840 (0.307) 0.766*** (0.022) 0.072** (0.022) 0.020*** (0.003)
Age2 1.003 (0.004) 1.003*** (0.001) -0.001*** (0.0002) -0.0003*** (0.0001)
Child 0–15 4.442*** (1.473) 1.510** (0.193) 0.00003 (0.021) -0.011 (0.010)
No partner (Ref. couple) 0.884 (0.269) 0.744* (0.096) 0.0002 (0.018) 0.022* (0.010)
Industry (Ref. SIC-KLMN)2
    SIC AB - 1.278 (0.659) -0.046 (0.202) 0.054 (0.038)
    SIC CDEF - 1.062 (0.257) 0.016 (0.084) 0.003 (0.016)
    SIC GI - 8.749*** (1.858) -0.199** (0.074) -0.090*** (0.017)
    SIC HJ - 2.946*** (0.721) 0.006 (0.086) -0.004) (0.018)
    SIC OPQ - 1.245 (0.227) 0.030 (0.067) -0.007 (0.013)
    SIC RSTU - 3.672*** (0.774) 0.138 (0.080) -0.080*** (0.016)
Self-employed - 2.962*** (0.480) -0.191*** (0.045) -0.270*** (0.014)
Female - 1.889*** (0.235) - -0.030** (0.010)
Ethnicity (Ref. White British)1
    White, other - 0.967 (0.268) - -0.024 (0.021)
    Asian - 0.723 (0.193) - 0.012 (0.019)
    Black - 0.823 (0.341) - 0.032 (0.030)
Qualification (Ref. high)
    Medium - 1.319* (0.161) - 0.003 (0.010)
    Low - 1.044 (0.250) - 0.020 (0.020)
Pre-pandemic characteristics (2019/2020)
Long-standing health cond. - 1.672*** (0.204) - -0.015 (0.010)
Net earnings/hour (logged) - 0.763** (0.765) - 0.047*** (0.009)
Hours worked - - - 0.028*** (0.0004)
Wave-obs. 2,644 16,622 17,956 15,098
Individuals 954 7,213 8,182 6,922
LR Chi2 / Wald Chi2 / F 214.5(9) 482.7(37) 9.04(8) 7421.8(38)

Source: USoc COVID-19 Study 2020–2021. Sample of respondents who were in work in Jan/Feb 2020 and are still in work at t (waves 7–9). Models include wave dummies and the RE models region dummies. Standard errors in brackets.

Significance level

***p<0.001

**p<0.01

*p<0.05.

1Categories with small cell sizes not shown.

2AB- agriculture, mining; CDEF-manufacturing, electricity, gas, water, construction; GI-retail, wholesale, hospitality; HJ-transport, information and communication; KLMN-finance, insurance, professional & admin. Services; OPQ-public admin., health, social, education; RSTU-other personal services.

We find that having short COVID (symptoms <5 weeks) or Long COVID 5–28 weeks, i.e. a duration covered by Statutory Sickness Pay according to employment protection law, increases the odds of not working (while still being in employment) (OR = 1.9–3.6, sd = 0.3–1.0). For those with Long COVID beyond the maximum period of employment protection in the UK of 28 weeks, we do not find a relationship with working zero hours.

In the random-effects model (Model 2, Table 3) also a previous long-standing health condition shows a positive relationship with working zero hours (OR = 1.7, sd = 0.2), although this effect is smaller relative to having short COVID (OR = 2.1, sd = 0.3) and Long COVID 5–28 weeks (OR = 3.6, sd = 1.0). The random-effects model also reveals a greater risk of working zero hours in industry sectors particularly affected by lockdowns (hospitality—GI, transportation—HJ and personal services—RSTU), women (OR = 1.9, sd = 0.2), the self-employed (OR = 2.96, sd = 0.5) and those on lower earnings (OR = 0.76, sd = 0.8).

Considering only those who are still working at least one hour per week (Models 3 and 4 in Table 3), neither of the COVID-19 symptoms groups display a relationship with the number of hours worked compared to those with no COVID-19 symptoms. Hence, the impact of Long COVID on working hours is due to workers not working at all rather than working reduced hours. This result is supported by additional analysis of the change in working hours between the COVID-19 surveys (waves 7–9) and January/February 2020 using the duration-based Long COVID variable and the same controls (see S1 Appendix). This shows that those with short COVID (<5 weeks) and Long COVID 5–28 weeks are associated with a significant reduction in working hours compared to those with no COVID-19 symptoms but those with Long COVID 29+ weeks do not work less (or more) than they did before the pandemic.

Furthermore, a previous long-standing health condition is also not related with reduced working hours (Model 4, Table 3). Instead we find that young people (age squared = -0.0003, sd = 0.0001), women (-0.03, sd = 0.01), working in retail and hospitality (GI—-0.09, sd = 0.02) and being self-employed (-0.27, sd = 0.01) are related with shorter working hours.

4.3 Mental health and well-being

Table 4 presents findings on the impact of Long COVID on worker’s mental health and well-being using the standardised GHQ-12 Likert score (Models 1–3) and the happiness scale from the GHQ-12 (Models 4–6). Two fixed-effects (FE) models are displayed for each outcome variable (Models 1 and 2, 4 and 5) whereby the second model for each adds hourly net earnings to the first model to control for the impact of lower (higher) income on mental health and well-being. Coefficients are displayed for the GHQ-12 score and odds ratios for the happiness scale.

Table 4. Standardised GHQ-12 score (coefficients) and happiness (odds ratios).

Co-variates GHQ-12 –coeff. Happiness–odds ratio1
M1 –FE M2 –FE M3 –RE M4 –FE M5 –FE M6 –RE
COVID-19 symptoms (Ref. none)
    <5 weeks -0.080** (0.024) -0.079** (0.028) -0.128*** (0.025) 0.862 (0.081) 0.840 (0.092) 0.731*** (0.064)
    5–28 weeks -0.230*** (0.056) -0.079 (0.070) -0.266*** (0.059) 0.496** (0.107) 0.659 (0.167) 0.445*** (0.089)
    29+ weeks -0.089 (0.084) -0.089 (0.098) -0.354*** (0.079) 0.509* (0.161) 0.620 (0.214) 0.295*** (0.079)
Age 0.007 (0.049) 0.036 (0.058) -0.005 (0.059) 0.956 (0.208) 0.934 (0.254) 0.995 (0.019)
Age2 0.0001 (0.0005) -0.0003 (0.0006) 0.0001* (0.0001) 1.005* (0.002) 1.005 (0.003) 1.0003 (0.0002)
Child 0–15 0.002 (0.044) -0.001 (0.055) -0.065** (0.022) 0.874 (0.152) 0.864 (0.188) 0.824* (0.062)
No partner (Ref. couple) -0.016 (0.040) -0.044 (0.048) -0.175*** (0.023) 0.924 (0.146) 0.966 (0.180) 0.554*** (0.042)
Industry (Ref. SIC-KLMN)2,3
    SIC CDEF 0.013 (0.185) -0.211 (0.232) 0.001 (0.039) 1.783 (1.284) 0.725 (0.667) 1.175 (0.149)
    SIC GI -0.011 (0.163) -0.189 (0.204) -0.057 (0.040) 0.827 (0.542) 0.696 (0.520) 0.967 (0.126)
    SIC HJ -0.087 (0.193) -0.283 (0.226) -0.074 (0.043) 0.982 (0.740) 0.485 (0.416) 0.899 (0.128)
    SIC OPQ -0.188 (0.152) -0.459* (0.188) -0.032 (0.029) 0.343 (0.225) 0.117** (0.093) 1.004 (0.098)
    SIC RSTU 0.127 (0.187) -0.101 (0.229) -0.006 (0.039) 1.617 (1.104) 0.842 (0.737) 0.991 (0.125)
Self-employed 0.004 (0.101) -0.094 (0.125) 0.041 (0.034) 1.238 (0.539) 1.103 (0.604) 1.138 (0.128)
Net earnings/hour (logged) - 0.038* (0.018) 0.063*** (0.013) - 1.060 (0.080) 1.156** (0.054)
Female - - -0.178*** (0.022) - - 0.610*** (0.045)
Ethnicity (Ref. White British)2
    White, other - - -0.007 (0.051) - - 0.988 (0.163)
    Asian - - -0.00002 (0.045) - - 0.978 (0.144)
    Black - - 0.174* (0.071) - - 2.068** (0.485)
Qualification (Ref. high)
    Medium - - 0.052* (0.023) - - 1.110 (0.082)
    Low - - 0.130*** (0.048) - - 1.319 (0.208)
Long-standing health cond. (2019) - - -0.262*** (0.023) - - 0.434*** (0.033)
Wave-obs. 19,514 15,042 13,841 11,562 8,168 13,864
Individuals 8,422 7,094 6,591 3,422 2,493 6,595
F / Wald Chi2(df) 13.72 8.90 658.4(37) 95.23 (13) 66.27 (14) 534.8(37)

Source: USoc COVID-19 Study 2020–2021. Sample of respondents who were in work in Jan/Feb 2020 and are still in work at t (waves 7–9). The original scores are reversed. Positive (negative) coefficients and ORs >1 (<1) indicate better (poorer) mental health and well-being. Wave dummies are included in all models and region dummies in the RE models. Standard errors in brackets.

Significance level

***p<0.001

**p<0.01

*p<0.05.

1Cut-off points not shown.

2Categories with small cell sizes not shown.

3CDEF-manufacturing, electricity, gas, water, construction; GI-retail, wholesale, hospitality; HJ-transport, information and communication; KLMN-finance, insurance, professional & admin. Services; OPQ-public admin., health, social, education; RSTU-other personal services.

We first consider findings for the GHQ-12. The first fixed-effects model shows a large negative and significant effect of Long COVID 5–28 weeks (-0.23, sd = 0.06) on mental health. This effect is not significant once earnings are controlled for (Model 2, Table 4). Suffering Long COVID for 29+ weeks is not significant in either fixed-effects model. Short COVID (<5 weeks) is significantly negatively associated with mental health in the fixed-effects models (-0.08, sd = 0.02). The short COVID effect on mental health is not influenced by earnings and remains statistically significant in Model 2 (-0.08, sd = 0.03).

The random-effects model (Model 3) (which assumes that the co-variates are not correlated with omitted variables) instead shows for all three COVID-19 symptom groups a large negative and significant relationship with mental health when earnings are controlled for (-0.13, sd = 0.03 - -0.35, sd = 0.08)–and this negative relationship is largest for the Long COVID group with a longer duration of the illness (29+ weeks). For them, the mental health score is reduced by 35% (-0.35, sd = 0.08)–and this effect is large when compared to all other co-variates.

Additional analysis in Table 5 confirms these results and aids interpretation. The dependent variable in Table 5 measures the change of individual’s GHQ-12 score between 2019 and during the pandemic surveys (in waves 7–9). The GHQ-12 for the year 2019 is linked to the COVID-19 surveys from the Understanding Society main panel interview. A negative (positive) value indicates a reduction (increase) in mental health. Otherwise the same models including all co-variates are used as in Table 4. Results from random-effects models (Model 4, Table 5) show that those with Long COVID 29+ weeks are also at risk of experiencing the greatest reduction in mental health after earnings are controlled for (-0.195, sd = 0.09) compared to not having COVID-19 symptoms. The effect is smaller for short COVID (-0.13, sd = 0.03) or Long COVID 5–28 weeks (-0.09, sd = 0.06). In the fixed-effects models (Models 1 and 2, Table 5), Long COVID 29+ weeks does not show an effect on mental health. A possible explanation of the difference between the random-effects and fixed-effects estimates may be that people adapt to working with the illness.

Table 5. Change in GHQ-12 between COVID-19 surveys (Jan-Sep 2021) and 2019, fixed-effects (FE) and random-effects (RE) panel models, coefficients and standard errors1.

Co-variates FE Model RE Model
M1 M2 M3 M4
COVID-19 symptoms (Ref. none)
    <5 weeks -0.092*** (0.026) -0.097** (0.030) -0.117*** (0.023) -0.127*** (0.027)
    5–28 weeks -0.248*** (0.061) -0.124 (0.075) -0.254*** (0.054) -0.085 (0.064)
    29+ weeks -0.100 (0.091) -0.124 (0.107) -0.193* (0.077) -0.195* (0.086)
Age -0.012 (0.053) 0.022 (0.063) 0.003 (0.006) 0.005 (0.007)
Age2 0.0003 (0.0005) -0.0001 (0.0006) -0.00002 (0.00006) -0.00006 (0.00007)
Child 0–15 (Ref. no) 0.017 (0.047) 0.017 (0.059) -0.031 (0.023) -0.059* (0.025)
No partner (Ref. couple) 0.013 (0.044) -0.016 (0.052) -0.018 (0.023) -0.043 (0.025)
Industry (Ref. SIC-KLMN)2,3
    SIC CDEF 0.092 (0.201) -0.180 (0.247) -0.072 (0.040) -0.085 (0.044)
    SIC GI 0.030 (0.175) -0.167 (0.215) -0.093* (0.040) -0.070 (0.045)
    SIC HJ 0.009 (0.210) -0.259 (0.240) -0.046 (0.045) -0.042 (0.049)
    SIC OPQ -0.125 (0.165) -0.431* (0.203) -0.028 (0.031) -0.030 (0.034)
    SIC RSTU 0.183 (0.202) -0.063 (0.242) -0.054 (0.039) -0.006 (0.043)
Self-employed (yes) -0.009 (0.110) -0.061 (0.134) -0.065* (0.033) 0.020 (0.038)
Net earnings/hour (logged) - 0.041* (0.019) - 0.031* (0.015)
Female (Ref. male) - - -0.060** (0.023) -0.045 (0.025)
Ethnicity (Ref. White British)2
    White, other - - 0.027 (0.052) 0.020 (0.058)
    Asian or Asian British - - 0.081 (0.047) 0.099 (0.052)
    Black or Black British - - 0.060 (0.074) 0.005 (0.081)
Highest qualification (Ref. high)
    Medium - - 0.022 (0.023) 0.053* (0.026)
    Low - - 0.089 (0.048) 0.119* (0.055)
Long-standing health cond. (2019) - - 0.073** (0.024) 0.105*** (0.027)
Constant -0.226 (1.407) -0.673 (1.649) -0.062 (0.147) -0.129 (0.170)
Wave-obs. 18,502 14,273 17,752 13,712
Individuals 7,896 6,664 7,726 6,514
F/Wald Chi2 12.94 8.43 258.98(36) 224.84(37)

Source: Understanding Society COVID-19 Study 2020–2021. Sample of respondents who were in work in Jan/Feb 2020 and are still in work at t (waves 7–9). Models include wave dummies and the RE models also region dummies.

Significance level

***p<0.001

**p<0.01

*p<0.05

1The change score is reversed and standardised. Positive (negative) values indicate an increase (decrease) in mental health.

2Categories with small cell sizes not shown.

3CDEF-manufacturing, electricity, gas, water, construction; GI-retail, wholesale, hospitality; HJ-transport, information and communication; KLMN-finance, insurance, professional & admin. Services; OPQ-public admin., health, social, education; RSTU-other personal services.

When the change in the GHQ-12 score between 2019 and during the pandemic is estimated, the Long COVID group with symptoms 5–28 weeks has significantly poorer mental health before earnings are controlled for (-0.25, sd = 0.05–0.06) (Models 1 and 3, Table 5) but there is no significant Long COVID effect after earnings are included in the models (Models 2 and 4, Table 5). Together with findings for this group in Table 4, earnings are likely to capture that in some (higher paid) jobs tasks are less physical and can be performed better with Long COVID symptoms or that employers may be more likely or better able to accommodate the needs of Long COVID sufferers [31].

Considering now the happiness findings in Table 4 (Models 4–6), these broadly confirm findings of the GHQ-12 mental health score. In the fixed-effects model, both Long COVID groups are affected by lower happiness before earnings are controlled for (OR = 0.50, sd = 0.1) (Model 4). The Long COVID effect is reduced and is not statistically significant anymore when earnings are controlled for (Model 5). In the random-effects model (Model 6), compared to the group with no COVID-19 symptoms, short COVID and Long COVID 5–28 weeks are associated with lower happiness (OR = 0.7, sd = 0.06 and OR = 0.44, sd = 0.09) while the odds ratio is smallest, indicating the greatest reduction in mental health, in the group with Long COVID of 29+ weeks (OR = 0.3, sd = 0.08).

As concerns other co-variates in Table 4, the fixed-effects models show negative effects on mental health and well-being of working in administration, human health and education (OPQ: -0.46, sd = 0.2; OR = 0.12, sd = 0.09) which is likely to reflect the increased job demand in these sectors. The random-effects models further show lower mental health and well-being of women compared to men (-0.18, sd = 0.02; OR = 0.61, sd = 0.05), a finding reported for the COVID-19 pandemic in existing studies [46].

5. Conclusions

Our findings provide evidence in between-group comparison of an impact of Long COVID on employment exit for those who have suffered from COVID-19 symptoms beyond the maximum period of statutory sickness leave (which is 28 weeks in the UK).

For those who remain in employment, we observe a negative impact of Long COVID on working hours. This stems primarily from working zero hours (sickness leave) and not from working fewer hours. As previously shown, working fewer hours can help accommodate a work-limiting disability [47] and therefore this finding may suggest a lack of accommodation by employers of Long COVID at work.

The in-work experiences of those with Long COVID were further investigated with the GHQ-12. We find large negative effects in between-group comparison on worker’s general mental health and their happiness for the Long COVID group with symptoms for 29+ weeks (beyond the maximum period of employment protection in the case of sickness leave). For this group, analysis of variation within the same individuals shows no negative Long COVID effect on mental health and well-being. We suggest that adaptations of how to live and work with Long COVID could be one possible explanation. Findings for the Long COVID group with symptoms 5–28 weeks are more mixed but suggest that negative impact on mental health is mediated by earnings and the possible job characteristics associated with higher/lower incomes. The findings therefore raise concerns about how workers on lower incomes cope with Long COVID in the workplace.

Despite the strength of our data (large population sample allowing for comparison group analysis, longitudinal design, information on pre-pandemic characteristics of the respondents), there are also limitations. The measure of weeks of COVID-19 symptoms since infection meant that we could derive a measure of Long COVID that incorporates risk of loss of employment. However, there may be inconsistencies in how people who fall ‘between’ full weeks have answered the question and therefore some people may be misclassified in this study. Some respondents with Long COVID who got reinfected with COVID-19 also did not answer the question on the duration of COVID-19 symptoms for their first infection. Given the study design, we were only able to investigate short-term effects of developing Long COVID on employment and mental health but not the longer-term effects of Long COVID on people’s likelihood to return to, or remain in, work. Since Long COVID could be identified only for three subsequence study waves (covering nine months in total), the data do not support an event history analysis which is why we estimate the probability of having moved from employment to non-employment with logistic regression models. Our study also does not include links between developing Long COVID with unemployment or the receipt of social benefits. These are important areas for further research in order to capture the full impacts of the pandemic, and to better understand how best to support people with Long COVID in the workplace.

Several policy implications arise from this research. In the specific context of the UK, the extension of Statutory Sickness Pay beyond 28 weeks and greater flexibility to manage partial (returns to) work would help to stem the flow out of employment of those with Long COVID. Financial support for employers to maintain employment until recovery from Long COVID would also help preserve employment.

Our findings further demonstrate that Long COVID poses a twin challenge to employers of providing adaptations and flexibility to manage the physical symptoms, as well as supporting improvements to mental health and well-being. There is also a legal point for employers in that a sizeable number of workers with Long COVID are likely to meet the definition of disability once they have had Long COVID for 12 months (following the Equality Act 2010 in the UK), and so have a right to receive reasonable workplace adjustments. Employers therefore have a lawful duty to consider and act on the needs of their workforce in relation to Long COVID once it reaches 12 months in duration.

Our research has demonstrated the importance of the workforce impacts of Long COVID. However, there is a need to better understand the diversity of employer responses and ‘what works’ in supporting employees with Long COVID. Organisational case studies of good Human Resource Management (HRM) practice around health management of fluctuating and comorbid health conditions, and examining inequalities in experiences, are needed to enable HRM practitioners to make the case for resources and focus on this area, as well to support compliance with legislation.

Supporting information

S1 Appendix. Sample description and additional models on work hours.

(DOCX)

pone.0306122.s001.docx (23KB, docx)

Data Availability

University of Essex, Institute for Social and Economic Research. (2021). Understanding Society: COVID-19 Study, 2020-2021. [data collection]. 11th Edition. UK Data Service. SN: 8644, DOI: 10.5255/UKDA-SN-8644-11 University of Essex, Institute for Social and Economic Research. (2022). Understanding Society: Waves 1-11, 2009-2020 and Harmonised BHPS: Waves 1-18, 1991-2009. [data collection]. 15th Edition. UK Data Service. SN: 6614, DOI: 10.5255/UKDA-SN-6614-16.

Funding Statement

The author(s) received no specific funding for this work.

References

  • 1.do Prado CB, Emerick GS, Cevolani Pires LB, Salaroli LB (2022) Impact of long-term COVID on workers: A systematic review protocol. PLoS ONE 17(9): e0265705. doi: 10.1371/journal.pone.0265705 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Soriano JB, Murthy S, Marshall JC, Relan P, Diaz JV (2022) A clinical case definition of post-COVID-19 condition by a Delphi consensus. Lancet Infect Dis 22: e102–07 doi: 10.1016/S1473-3099(21)00703-9 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Davis HE, Assaf GS, McCorkell L, Wei H, Low RJ, Re’em Y et al. (2022) Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. EClinicalMedicine 38 (2021) 101019, 10.1016/j.eclinm.2021.101019 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Burton C, Dawes H, Goodwill S, Thelwell M, Dalton C (2023) Within and between-day variation and associations of symptoms in Long Covid: Intensive longitudinal study. PLoS ONE 18(1): e0280343. doi: 10.1371/journal.pone.0280343 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Brown DA, O’Brien KK (2021) Conceptualising Long COVID as an episodic health condition. BMJ Global Health 2021;6: e007004. doi: 10.1136/bmjgh-2021-007004 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.ONS (2022) Prevalence of ongoing symptoms following coronavirus (COVID-19) infection in the UK: 1 September 2022. ONS Statistical bulletin. [Google Scholar]
  • 7.Buttery S, Philip KEJ, Williams P, Fallas A, West B, Cumella A et al. (2021) Patient symptoms and experience following COVID-19: results from a UK-wide survey. BMJ Open Resp Res 2021;8: e001075. doi: 10.1136/bmjresp-2021-001075 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Thompson EJ, Williams DM, Walker AJ, Mitchell RE, Niedzwiedz CL, Yang TC et al. (2022) Long COVID burden and risk factors in 10 UK longitudinal studies and electronic health records. Nature Communications 13: 3528. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Ziauddeen N, Gurdasani D, O’Hara ME, Hastie C, Roderick P, Yao G, et al. (2022) Characteristics and impact of Long Covid: Findings from an online survey. PLoS ONE 17(3): e0264331. doi: 10.1371/journal.pone.0264331 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Davis HE, McCorkell L, Moore Vogel J, Topol EJ (2023) Long COVID: major findings, mechanisms and recommendations. Nature Reviews Microbiology 21:133–146. doi: 10.1038/s41579-022-00846-2 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.ONS (2022). Self-reported Long COVID after Two Doses of a Coronavirus (COVID-19) Vaccine in the UK. [Dataset]. [Google Scholar]
  • 12.Lelii M, O’Brien L, Hancock L (2023) Rising ill-health and economic inactivity because of long-term sickness, UK: 2019 to 2026. Office for National Statistics, 26 July 2023. [Google Scholar]
  • 13.Avendano M, Berkman LF (2014) Labor Markets, Employment Policies, and Health. In: Berkman LF, Kawachi I, Glymour MM (eds.) Social Epidemiology, Oxford University Press, pp. 182–233. [Google Scholar]
  • 14.Knuppel A, Boyd A, Macleod J, Chaturvedi N, Williams DM, 2024. The long COVID evidence gap. The Lancet, online first, 10.1016/S0140-6736(24)00744-X [DOI] [PubMed] [Google Scholar]
  • 15.Cooper E, Lound A, Atchison CJ, Whitaker M, Eccles C, Cooke GS, et al. (2023) Awareness and perceptions of Long COVID among people in the REACT programme: Early insights from a pilot interview study. PLoS ONE 18(1): e0280943. doi: 10.1371/journal.pone.0280943 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Pantelic M, Ziauddeen N, Boyes M, O’Hara ME, Hastie C, Alwan NA (2022) Long Covid stigma: Estimating burden and validating scale in a UK-based sample. PLoS ONE 17(11): e0277317. doi: 10.1371/journal.pone.0277317 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Jones MK, McVicar D (2020) Estimating the Impact of Disability Onset on Employment. Social Science & Medicine 255:113001. doi: 10.1016/j.socscimed.2020.113001 [DOI] [PubMed] [Google Scholar]
  • 18.Castro-Marrero J, Faro M, Zaragoza MC, Aliste L, de Sevilla TF, Alegre J (2019) Unemployment and work disability in individuals with chronic fatigue syndrome/myalgic encephalomyelitis. BMC Public Health 19:840. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Kingdon CC, Bowman EW, Curran H, Nacul L, Lacerda EM (2018) Functional Status and Well-Being in People with Encephalomyelitis/Chronic Fatigue Syndrome Compared with People with Multiple Sclerosis and Healthy Controls. Pharmaco Economics Open 2: 381–392. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Schuring M, Robroek SJ, Otten FW, Arts CH, Burdorf A (2013) The effect of ill health and socioeconomic status on labor force exit and re-employment: a prospective study with ten years follow-up in the Netherlands. Scand J Work Environ Health 39(2):134–143. doi: 10.5271/sjweh.3321 [DOI] [PubMed] [Google Scholar]
  • 21.Jones M (2016) Disability and perceptions of work and management. Br. J. of Ind. Relat., 54(1), 83–113. [Google Scholar]
  • 22.Schur L, Kruse D, Blasi J, Blanck P (2009). Is disability disabling in all workplaces? Workplace disparities and corporate culture. Industrial Relations 48:381–341. [Google Scholar]
  • 23.Stone DL, Colella A (1996) A Model of Factors Affecting the Treatment of Disabled Individuals in Organizations. Acad Manage Rev 21(2):352–401. [Google Scholar]
  • 24.Schur L, Nishii L, Adya M, Kruse D, Bruyère SM, Blanck P (2014) Accommodating Employees With and Without Disabilities. Hum. Resour. Manage. 53(4): 593–621. [Google Scholar]
  • 25.Hossain MM, Das J, Rahman F, Nesa F, Hossain P, Islam AMK, et al. (2023) Living with “long COVID”: A systematic review and metasynthesis of qualitative evidence. PLoS ONE 18(2): e0281884. doi: 10.1371/journal.pone.0281884 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Kennelly CE, Nguyen ATP, Sheikhan NY, Strudwick G, Ski CF, Thompson DR, et al. (2023) The lived experience of long COVID: A qualitative study of mental health, quality of life, and coping. PLoS ONE 18(10): e0292630. doi: 10.1371/journal.pone.0292630 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Blanchflower DG, Bryson A (2023) Long COVID in the United States. PLoS ONE 18(11): e0292672. doi: 10.1371/journal.pone.0292672 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Zakia H, Pradana K, Iskandar S (2023) Risk factors for psychiatric symptoms in patients with long COVID: A systematic review. PLoS ONE 18(4): e0284075. doi: 10.1371/journal.pone.0284075 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Aiyegbusi OL, Hughes SE, Turner G, Cruz Rivera S, McMullan C, Chandan JS et al. (2021) Symptoms, complications and management of long COVID: a review. J R Soc Med. 114(9): 428–442. doi: 10.1177/01410768211032850 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Shelley J, Hudson J, Mackintosh KA, Saynor ZL, Duckers J, Lewis KE et al. (2021) ‘I Live a Kind of Shadow Life’: Individual Experiences of COVID-19 Recovery and the Impact on Physical Activity Levels. International Journal of Environmental Research and Public Health. 18, 11417. doi: 10.3390/ijerph182111417 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Nielsen K, Yarker J (2023) “It’s a rollercoaster”: the recovery and return to work experiences of workers with long COVID. Work & Stress 1–29. [Google Scholar]
  • 32.Waters T, Wernham T (2022) Long COVID and the labour market. IFS Briefing Note BN246. [Google Scholar]
  • 33.Van Beukering IE, Smits SJC, Jassens KME, Bogaers RI, Joosen MCW, Bakker M et al. (2022) In What Ways Does Health Related Stigma Affect Sustainable Employment and Well-Being at Work? A Systematic Review. Journal of Occupational Rehabilitation 32:365–379. doi: 10.1007/s10926-021-09998-z [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.TUC (2023) Workers’ experiences of Long COVID London: Trade Unions Congress. https://www.tuc.org.uk/sites/default/files/2023-03/LongCovidatWork23.pdf [Google Scholar]
  • 35.Taylor M, Marsh G, Nicol D, Broadbent P (2017) Good Work: The Taylor Review of Modern Working Practices. London, Department for Business, Energy & Industrial Strategy. [Google Scholar]
  • 36.Spasova S, Bouget D, Vanhercke B (2016) Sick pay and sickness benefit schemes in the European Union: Background report for the Social Protection Committee’s In-depth Review on sickness benefits, ESPN, Brussels, European Commission [Google Scholar]
  • 37.Department for Work and Pensions (2015) Understanding the journeys from work to Employment and Support Allowance (ESA). DWP Research Report 902. [Google Scholar]
  • 38.Black CD, Frost D (2011). Health at work-an independent review of sickness absence. HMS. Department for Work and Pensions. [Google Scholar]
  • 39.Holland P, Collins AM (2022) Supporting and retaining employees with rheumatoid arthritis: The importance of workplace social support. Int. J. Hum. Resour. Manag., 33(3): 539–560. [Google Scholar]
  • 40.University of Essex, Institute for Social and Economic Research. (2021). Understanding Society: COVID-19 Study, 2020–2021. [data collection]. 11th Edition. UK Data Service. SN:8644, doi: 10.5255/UKDA-SN-8644-11 [DOI] [Google Scholar]
  • 41.Institute for Social and Economic Research (2021) Understanding Society COVID-19 User Guide. Version 10.0, October 2021. Colchester: University of Essex. [Google Scholar]
  • 42.University of Essex, Institute for Social and Economic Research. (2022). Understanding Society: Waves 1–11, 2009–2020 and Harmonised BHPS: Waves 1–18, 1991–2009. [data collection]. 15th Edition. UK Data Service. SN: 6614, doi: 10.5255/UKDA-SN-6614-16 [DOI] [Google Scholar]
  • 43.Oswald AJ, Proto E., Sgroi D (2015) Happiness and Productivity. J Labor Econ 33(4): 789–822. [Google Scholar]
  • 44.Thomson RM, Ingelström E, Purba AK, Shimonovich M, Thomson H, McCartney G et al. (2022) How do income changes impact on mental health and wellbeing for working-age adults? A systematic review and meta-analysis. The Lancet Public Health 7(6), E515–E528. doi: 10.1016/S2468-2667(22)00058-5 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Sudre CH, Murray B, Varsavsky T, Graham MS, Penfold RS, Bowyer RC et al. (2021) Attributes and predictors of long COVID. Nature Medicine 27:626–631. doi: 10.1038/s41591-021-01292-y [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Proto E, Quintana-Domeque C (2021) COVID-19 and mental health deterioration by ethnicity and gender in the UK, PLoS ONE doi: 10.1371/journal.pone.0244419 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.Jones MK (2007) Does part-time employment provide a way of accommodating a disability? The Manchester School 75(6), 695–716. [Google Scholar]

Decision Letter 0

Gabriel A Picone

22 Apr 2024

PONE-D-24-03100The impact of Long COVID on workers' employment and mental healthPLOS ONE

Dear Dr. Reuschke,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by Jun 06 2024 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Gabriel A. Picone

Academic Editor

PLOS ONE

Journal Requirements:

1. When submitting your revision, we need you to address these additional requirements.

Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at 

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. Thank you for uploading your study's underlying data set. Unfortunately, the repository you have noted in your Data Availability statement does not qualify as an acceptable data repository according to PLOS's standards.

At this time, please upload the minimal data set necessary to replicate your study's findings to a stable, public repository (such as figshare or Dryad) and provide us with the relevant URLs, DOIs, or accession numbers that may be used to access these data. For a list of recommended repositories and additional information on PLOS standards for data deposition, please see https://journals.plos.org/plosone/s/recommended-repositories.

3. Please include your full ethics statement in the ‘Methods’ section of your manuscript file. In your statement, please include the full name of the IRB or ethics committee who approved or waived your study, as well as whether or not you obtained informed written or verbal consent. If consent was waived for your study, please include this information in your statement as well. 

4. Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Yes

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: Yes

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: Summary:

This paper investigates the impact of Long COVID-19 on employment and mental health using the Understanding Society COVID-19 Study 2020-2021 in the UK. Employing fixed and random effect models, the authors discovered that Long COVID does not influence employment status but significantly increases the likelihood of working zero hours. Additionally, Long COVID is associated with mental health issues and reduced happiness. The findings contribute to understanding broader health issues like chronic fatigue syndrome and offer policy implications for COVID-19 and similar health conditions on employment.

Major comments:

1. The context and existing evidence section extensively reviews the current literature, facilitating a comprehensive understanding of the topic. However, the authors did not explain why utilizing Long COVID would contribute to the existing literature. Consider adding more details and explaining the novelty/difference of employing Long COVID as opposed to using other health issues like depression and chronic pain.

2. Authors tried to differentiate the effect of the different durations of Long-term COVID-19 on various outcomes, and those different exposures would help us better understand the effect of Long-term COVID. Table 1 shows the total effect first, then the differential effect with different durations of employment. However, the authors did not do so in Table 2 and onward. Consider showing the total effect first (Long COVID compared to short COVID/No symptoms), then show the differential effect. Or clarify why the exposure/variables of interests are different for different outcomes.

3. For Table 1 and onward, the unique individuals of the fixed effect model are 407, and the random effect are 7092. Why those two numbers are so different? Does it mean that only 407 individuals repeated the survey, thus compared within person are much less? If so, can you please report the survey follow-up rate? If less than 10% of the survey respondents repeated the survey, would you consider selection bias might be a major weakness of this study?

4. In the conclusion section, authors acknowledge insufficient data for exploring Long COVID's impact on long-term employment. Consequently, the study concentrates solely on short-term effects. Consider aligning this limitation in the introduction/context sections and changing the narrative to short-term effects rather than giving an impression the study would study both.

5. The main paper flows well, but the abstract needs improvement for better clarity. Consider reworking it to include reporting insignificant results, clarify the comparison group, provide more details on the regression model, and succinctly highlight the study's contribution and policy implications.

Minor comments:

1. Suggest adding more details to the title: The Impact of Long COVID on Workers’ Employment and Mental Health: Empirical Evidence from the UK

2. Abstract line 33. “The results show that Group 2 is at higher risk of exiting employment.” What is the comparison group? Compared to those who did not have long COVID?

3. For section 3.1.1, can you add more details as to why you created four cohorts for this study? Do you expect/hypothesize people who experience long duration Long COVID, such as symptoms of 29 weeks or more, have a more significant impact on their employment and mental health? Why not study total effect: Long COVID or not despite the duration.

4. For section 3.1.1, can you confirm if someone had 4 weeks and 3 days of COVID symptoms, they will not be included? The current definition only includes 0 to 4 weeks, 5 to 28 weeks, or 29 weeks. Or is it included in the 5 to 28 weeks cohorts? Please make it clearer.

5. For section 3.1.2, do you define employment as those employed at the time of the survey? For most labor studies, we would define employment as either employed or looking for jobs at the time of the survey. Can you please clarify and explain why you defined employment in this way?

6. For section 3.2, can you add more details about why survey responses in waves 7-9 (January-September 2021) were chosen, not other waves?

Reviewer #2: The article makes relevant contributions related to an emerging problem in global public health, which is the burden of Covid-19 sequelae and its influence on occupational health.

There is a need for adjustments to improve the quality of the manuscript.

The methodology, with regard to evaluations and statistics, needs to be described more clearly to the reader. Details about which statistical program was carried out are missing.

Present the description of the tables more clearly in the manuscript. Highlight the values of significant findings in the text.

The discussion needs to be in-depth. What are the limitations of the study? It wasn't clear.

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: Yes: Lei Lv

Reviewer #2: No

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

PLoS One. 2024 Jun 26;19(6):e0306122. doi: 10.1371/journal.pone.0306122.r002

Author response to Decision Letter 0


16 May 2024

REVIEWER #1

Major comments:

1. The context and existing evidence section extensively reviews the current literature, facilitating a comprehensive understanding of the topic. However, the authors did not explain why utilizing Long COVID would contribute to the existing literature. Consider adding more details and explaining the novelty/difference of employing Long COVID as opposed to using other health issues like depression and chronic pain.

Response: Long COVID is a new ‘disease’ or syndrome, often with relatively serious symptoms and substantial prevalence in the population, making it worthy of investigation in an empirical sense to establish an evidence baseline of its social patterns in prevalence, duration and impacts. Conceptually, investigating Long COVID contributes to existing understandings of complex comorbidity syndromes, which are often difficult or impossible to diagnose in a strict medical sense so remain under-recognised, under-reported and under-treated.

In the introduction, we reference figures on the scale of Long COVID and the increased risk of the working-age population to develop Long COVID. We add in section 2 (context and existing evidence), after reviewing relevant related literature on disability and employment on page 6 (lines 122-127), that Long COVID adds to previous studies on work-limiting conditions through focussing on an illness which is often associated, similar to chronic fatigue syndrome, with comorbid health conditions and people often do not receive appropriate treatment and are not eligible for disability benefits. The latter informs our novel measure of the duration of COVID-19 symptoms which is linked with the reviewer’s next comment.

2. Authors tried to differentiate the effect of the different durations of Long-term COVID-19 on various outcomes, and those different exposures would help us better understand the effect of Long-term COVID. Table 1 shows the total effect first, then the differential effect with different durations of employment. However, the authors did not do so in Table 2 and onward. Consider showing the total effect first (Long COVID compared to short COVID/No symptoms), then show the differential effect. Or clarify why the exposure/variables of interests are different for different outcomes.

Response: We have addressed this issue in various places to make clearer why we use a measure of Long COVID with different durations of symptoms.

We add this paragraph at the end of the context and literature section (section 2) on page 9 (lines 178-184):

“Together, these gaps in the sick pay system and inequalities in the coverage of occupational health support represent important limitations in the provision of support to allow individuals to remain in work while managing health conditions in the UK. However, no existing study has investigated the association between work outcomes of Long COVID and the length of employment protection in law and how the employment and in-work experiences of Long COVID may be mitigated by certain worker or job characteristics (e.g. skills level, earnings).”

We clarify further in section 3.1.1 on the use of measures (page 11, lines 225ff):

“Our focus is on the health-related COVID-19 impact on employment and in-work experiences of those who remain in work. Longer-term periods of ill health that extend the maximum period of Statutory Sickness Pay of 28 weeks in the UK, often precipitate the termination of employment [35]. This is the maximum period we expect especially low-paid workers and those in more insecure employment positions to be more likely to leave employment. Those on lower income and in lower skilled jobs in particular, may need to work even if they are unwell which may result in lower in-work experiences. This is the rationale for deriving two groups of individuals with Long COVID for this study: 1) 5-28 weeks of symptoms and 2) symptoms of 29 weeks and more …

This is our preferred measure of Long COVID for this study. However, when estimating employment exit we also use a binary (total) measure of Long COVID (see section 3.3.1). This measure defines as Long COVID all those who reported that they have not recovered from a COVID-19 infection or who had experienced coronavirus symptoms for five weeks and more [32]. The comparison group on this binary measure are respondents with no COVID-19 symptoms or who recovered from a coronavirus infection.”

We completely revised section 3.3.1 (employment exit) as follows (page 16):

“We estimate the probability of having moved from employment to non-employment with logistic regression models. Unfortunately, we cannot fit a logistic regression model with fixed effects using our duration-based measure. The model requires that people have experienced between subsequent waves changes in the work status and COVID-19 symptoms categories. We can fit a logistic regression model with fixed effects using the binary (total) Long COVID measure (COVID-19 symptoms 5+ weeks vs <5 weeks including no symptoms and recovery from COVID-19). We report random-effects findings for the duration-based measure of Long COVID (no symptom, short COVID, Long COVID 5-28 weeks, Long COVID 29+ weeks).”

We delete in Table 2 (previously Table 1) the column showing estimates of the random-effects model with the binary Long COVID measure to be more consistent. We therefore consistently display random-effects findings only for the duration-based measure.

3. For Table 1 and onward, the unique individuals of the fixed effect model are 407, and the random effect are 7092. Why those two numbers are so different? Does it mean that only 407 individuals repeated the survey, thus compared within person are much less? If so, can you please report the survey follow-up rate? If less than 10% of the survey respondents repeated the survey, would you consider selection bias might be a major weakness of this study?

Response: These fixed effects models measure change. Model 1 in Table 1 (this is not Table 2) therefore only includes observations from individuals who exited employment and developed Long COVID or recovered from Long COVID. All individuals who are still in employment and who never developed Long COVID are excluded. Individuals who reported Long COVID in all waves (waves 7-9) are also excluded. This explains why the number of individuals is small compared to the random effects model that includes all observations. The advance of the fixed effects method is that it is quasi-experimental. The disadvantage is that those with continuous Long COVID are not included. We therefore also show findings from the random effects models where the latter are included.

We fully revise the section (3.3) that explains the analytical framework as follows (on pages 15-16):

“The fixed-effects panel model estimates within-individual variation and requires that the same individual is observed twice, once when they experienced COVID-19 symptoms and once when they did not experience COVID-19 symptoms. These models include an error term that represents individual-specific unmeasured characteristics and therefore allow to control for unobserved heterogeneity due to time-invariant omitted variables and traits. The disadvantage is, however, that individuals in our study who experienced Long COVID in all three subsequent waves, are not included in the statistical analysis.

This is why we also report random-effects models which estimate between-individual variation and within-individual variation. These models, however, assume that the error term is not correlated with unobserved time-invariant (and time-variant) variables. Random-effects models allow the investigation of time-invariant characteristics which we also report. We include as time-invariant variables pre-COVID-19 job characteristics of the respondents which we link to the survey data from the main panel study.”

We also expand the description of the data and include information on the retainment of participants in the sample (in sections 3.1 and 3.1.1) underlining the high-quality of the data. The retainment over the whole study comprising nine waves (18 months) is 40.5%. Across waves 7-9 which our analysis draws on, 63.5% remained in the study in each of the three waves (over nine months).

New text is added on pages 9-10 on the panel nature of the data (lines 198-203):

“In the first wave, 17,745 individuals completed the survey [41]. Individuals could also join the study in waves 2-4. In total, across all nine waves, 19,763 individuals participated in the study. However, as in all longitudinal surveys, there is an issue with panel attrition. From all individuals who participated in the study, 40.5% participated in every wave. A relatively high proportion of 9.5% only participated in wave 1 (April 2020).”

This information is added on page 10 specifically for the retention in waves 7-9 (lines 220-223):

“From the initially recruited participants, n= 15,249 were still in the study at least once over the waves 7-9 and n=9,678 individuals were in the study in each of these three waves our study is based on.”

4. In the conclusion section, authors acknowledge insufficient data for exploring Long COVID's impact on long-term employment. Consequently, the study concentrates solely on short-term effects. Consider aligning this limitation in the introduction/context sections and changing the narrative to short-term effects rather than giving an impression the study would study both.

Response: We agree with the reviewer. Consequently, we have changed the sentence in the introduction as follows (pages 5-6, lines 108-110)):

“We use a large national longitudinal survey of people 16 years and older and multi-variate panel regression modelling to estimate how the development of Long COVID has changed individuals’ employment and in-work experience.”

The short-term nature of the study is added in the conclusion in the context of discussing limitations of the study (on page 31, lines 626-631):

“Given the study design, we were only able to investigate short-term effects of developing Long COVID on employment and mental health but not the longer-term effects of Long COVID on people’s likelihood to return to, or remain in, work. Since Long COVID could be identified only for three subsequence study waves (covering nine months in total), the data do not support an event history analysis which is why we estimate the probability of having moved from employment to non-employment with logistic regression models.”

5. The main paper flows well, but the abstract needs improvement for better clarity. Consider reworking it to include reporting insignificant results, clarify the comparison group, provide more details on the regression model, and succinctly highlight the study's contribution and policy implications.

Response: Many thanks for these suggestions. In response, we now use a structured abstract approach in order to succinctly cover all these points. The reference group is added.

Minor comments:

1. Suggest adding more details to the title.

Response: The title has been amended to provide more detail:

“Impacts of Long COVID on workers: a longitudinal study of employment exit, work hours and mental health in the UK”

2. Abstract line 33. “The results show that Group 2 is at higher risk of exiting employment.” What is the comparison group? Compared to those who did not have long COVID?

Response: The comparison group is now added.

3. For section 3.1.1, can you add more details as to why you created four cohorts for this study? Do you expect/hypothesize people who experience long duration Long COVID, such as symptoms of 29 weeks or more, have a more significant impact on their employment and mental health? Why not study total effect: Long COVID or not despite the duration.

Response: We can see that the reference to the 28 weeks of Statutory Sickness Pay in Section 3.1.1 was too brief and that the use of an acronym was not helpful (“Given our focus on the health-related COVID-19 impact on employment, we further identify whether respondents have suffered from Long COVID for more than 28 weeks corresponding to the maximum period of SSP.”). We therefore changed the text on page 11 (lines 225ff.) as follows:

“Our focus is on the health-related COVID-19 impact on employment and in-work experiences of those who remain in work. Longer-term periods of ill health that extend the maximum period of Statutory Sickness Pay of 28 weeks in the UK, often precipitate the termination of employment [35]. This is the maximum period we expect especially low-paid workers and those in more insecure employment positions to be more likely to leave employment. Those on lower income and in lower skilled jobs in particular, may need to work even if they are unwell which may result in lower in-work experiences. This is the rationale for deriving two groups of individuals with Long COVID for this study: 1) 5-28 weeks of symptoms and 2) symptoms of 29 weeks and more. For comparison, we define a further two groups of respondents with 3) COVID-19 symptoms of up to four weeks (short COVID) after a COVID-19 infection and 4) a group with no symptoms including recovery from a previous coronavirus infection (used as reference group in the modelling). This is our preferred measure of Long COVID for this study. However, when estimating employment exit we also use a binary (total) measure of Long COVID (see section 3.3.1). This measure defines as Long COVID all those who reported that they have not recovered from a COVID-19 infection or who had experienced coronavirus symptoms for five weeks and more [32]. The comparison group on this binary measure are respondents with no COVID-19 symptoms or who recovered from a coronavirus infection.”

4. For section 3.1.1, can you confirm if someone had 4 weeks and 3 days of COVID symptoms, they will not be included? The current definition only includes 0 to 4 weeks, 5 to 28 weeks, or 29 weeks. Or is it included in the 5 to 28 weeks cohorts? Please make it clearer.

Response: The question about the length of COVID-19 symptoms was: “For how many weeks have you experienced coronavirus symptoms?” with the response: [numeric textbox] weeks (see page 9). There were no instructions added to this question. Values ranged from 1-60 and therefore respondents could not answer 4.5 weeks, for example, if they had symptoms for 4 weeks and 3 days. We can therefore only assume that most people will have provided answers for the full week, i.e. in the case of 4 weeks and 3 days they would have chosen 4 weeks. We also changed the wording and now refer in the text to having coronavirus symptoms for five weeks and more instead of saying more than 4 weeks – which we agree may be confusing.

We are grateful for this comment as this points to a potential minor bias of the study addressing also the other reviewer’s feedback on limitations of the data. We add this issue as a limitation of the data in the discussion section (page 31, 622-624).

5. For section 3.1.2, do you define employment as those employed at the time of the survey? For most labor studies, we would define employment as either employed or looking for jobs at the time of the survey. Can you please clarify and explain why you defined employment in this way?

Response: Employment is defined in this study as being in employment (paid employment or self-employment). The unemployed are not included in this definition. This is conceptually meaningful in our study as we investigate the association between Long COVID and the risk of leaving employment, but statistically the unemployed are not in the population at risk of this outcome (i.e. one needs to be employed to be at risk of leaving employment).

The data would also not allow us to differentiate between those who are economically active (employed or unemployed) or economically inactive as the possible responses to the question “Thinking about your situation now. Even if you did not do any paid work last week, are you currently employed or self-employed?” are as follows: 1) Yes, employed only, 2) yes, self-employed only, 3) both employed and self-employed, 4) No. Both the unemployed and economically inactive fall into the fourth category.

We fully revise the first paragraph in section 3.1.2 (measuring em

Attachment

Submitted filename: Response to reviewers.docx

pone.0306122.s002.docx (34.5KB, docx)

Decision Letter 1

Gabriel A Picone

12 Jun 2024

Impacts of Long COVID on workers: a longitudinal study of employment exit, work hours and mental health in the UK

PONE-D-24-03100R1

Dear Dr. Reuschke,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager® and clicking the ‘Update My Information' link at the top of the page. If you have any questions relating to publication charges, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Gabriel A. Picone

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #1: All comments have been addressed

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: (No Response)

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

**********

Acceptance letter

Gabriel A Picone

17 Jun 2024

PONE-D-24-03100R1

PLOS ONE

Dear Dr. Reuschke,

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now being handed over to our production team.

At this stage, our production department will prepare your paper for publication. This includes ensuring the following:

* All references, tables, and figures are properly cited

* All relevant supporting information is included in the manuscript submission,

* There are no issues that prevent the paper from being properly typeset

If revisions are needed, the production department will contact you directly to resolve them. If no revisions are needed, you will receive an email when the publication date has been set. At this time, we do not offer pre-publication proofs to authors during production of the accepted work. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few weeks to review your paper and let you know the next and final steps.

Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

If we can help with anything else, please email us at customercare@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Gabriel A. Picone

Academic Editor

PLOS ONE

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 Appendix. Sample description and additional models on work hours.

    (DOCX)

    pone.0306122.s001.docx (23KB, docx)
    Attachment

    Submitted filename: Response to reviewers.docx

    pone.0306122.s002.docx (34.5KB, docx)

    Data Availability Statement

    University of Essex, Institute for Social and Economic Research. (2021). Understanding Society: COVID-19 Study, 2020-2021. [data collection]. 11th Edition. UK Data Service. SN: 8644, DOI: 10.5255/UKDA-SN-8644-11 University of Essex, Institute for Social and Economic Research. (2022). Understanding Society: Waves 1-11, 2009-2020 and Harmonised BHPS: Waves 1-18, 1991-2009. [data collection]. 15th Edition. UK Data Service. SN: 6614, DOI: 10.5255/UKDA-SN-6614-16.


    Articles from PLOS ONE are provided here courtesy of PLOS

    RESOURCES